Company intelligence / Profile preview

National Research Institute

Various, Multiple, United States

Ownership: Private
Development stage: Other

Overview

Prior to acquisition, NRI operated 11 clinical trial sites on the US West Coast, was notable for recruiting in minority populations, and participated in pivotal COVID-19 vaccine clinical trials.

Therapeutic areas: Infectious DiseasesMultiple
Modalities: Small moleculeBiologicMonoclonal antibodyVaccine
Industry: Contract Research Organization

Partnerships

Pharmaceutical sponsors for clinical trials

Beyond the preview

Go deeper on National Research Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on National Research Institute.

Explore the full profile